Woodcasting Versus Thermoplast Splint in CMC Arthroplasty

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

26 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-10-03

Study Completion Date

2025-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is a prospective, randomized, nonblinded trial to evaluate patient preference in splints after having a carpometacarpal arthroplasty.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Influence of Custom Orthosis Post Carpometacarpal (CMC) Arthroplasty

NCT05307510

Thumb Osteoarthritis

COMPLETED NA

3D-Printed Hand Orthosis Versus Thermoplastic Orthosis

NCT05896410

Thumb Osteoarthritis CMC Splints

UNKNOWN NA

CMC Arthritis - Neoprene Vs. Thermoplast Short Opponens Splinting

NCT00438763

Carpometacarpal Thumb Arthritis

COMPLETED

CMC (Carpometacarpal) OA (Osteoarthritis) Thumb Splint Study

NCT00705146

Osteoarthritis

COMPLETED PHASE2

Variable Immobilization Protocol for Arthroplasty of the Carpometacarpal Joint of the Thumb

NCT04828954

Thumb Osteoarthritis

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients undergoing carpometacarpal arthroplasty will be randomized into the woodcast or thermoplast splint after their surgery to see which is preferred using compliance and surveys.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Carpometacarpal (CMC) Joint Arthritis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Woodcasting Splint

Woodcasting is an already FDA approved on the market product that is not used a lot so for the purpose of the study we would like to show superior outcomes.

Group Type EXPERIMENTAL

Woodcasting Splint

Intervention Type OTHER

This is the experimental group so we could see the outcomes and preference for patients using surveys and compliance scores

Thermoplastic Splint

Thermoplastic splints is an FDA approved on the market orthrosis that is used by Occupational Therapists which is standard of care for patients that undergo CMC arthroplasty.

Group Type ACTIVE_COMPARATOR

Control (Standard treatment)

Intervention Type OTHER

Thermoplastic splints are standard of care treatment for patients after CMC arthroplasty. We will use the data from this group as the comparator to the experimental group.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Woodcasting Splint

This is the experimental group so we could see the outcomes and preference for patients using surveys and compliance scores

Intervention Type OTHER

Control (Standard treatment)

Thermoplastic splints are standard of care treatment for patients after CMC arthroplasty. We will use the data from this group as the comparator to the experimental group.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients over the age of 18 years old.
* Intact Medical Decision Making
* Eligible for Surgical Intervention
* Willing to comply with all aspects of the treatment and evaluation schedule over 6 weeks